HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 63 filers reported holding HARPOON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $13,471 | -54.2% | 18,973 | -52.0% | 0.00% | – |
| Q1 2023 | $29,395 | +0.6% | 39,500 | -1.9% | 0.00% | – |
| Q4 2022 | $29,214 | +71.8% | 40,257 | +135.4% | 0.00% | – |
| Q3 2022 | $17,000 | -94.3% | 17,100 | -89.1% | 0.00% | – |
| Q2 2022 | $299,000 | +115.1% | 156,496 | +460.9% | 0.00% | – |
| Q1 2022 | $139,000 | -73.4% | 27,900 | -59.6% | 0.00% | – |
| Q4 2021 | $522,000 | -36.3% | 69,103 | -33.3% | 0.00% | – |
| Q3 2021 | $819,000 | -37.3% | 103,630 | +9.9% | 0.00% | – |
| Q2 2021 | $1,307,000 | -46.8% | 94,267 | -19.7% | 0.00% | – |
| Q1 2021 | $2,456,000 | +50.7% | 117,351 | +19.6% | 0.00% | – |
| Q4 2020 | $1,630,000 | +31.8% | 98,136 | +34.8% | 0.00% | – |
| Q3 2020 | $1,237,000 | +61.1% | 72,784 | +57.5% | 0.00% | – |
| Q2 2020 | $768,000 | – | 46,221 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
| MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
| ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
| Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
| Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
| Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
| DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
| Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |